Herpes simplex encephalitis in adults and older children

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

• Herpes simplex encephalitis (HSE) is a neurologically devastating illness associated with substantial morbidity and mortality in adults and older children. • The correct recognition of HSE, and distinguishing it from other forms of encephalitis, brain abscess or mimicking disorders early in the course of evaluation facilitates treatment decisions when neurologic complications occur. • The combination of clinical characteristics, magnetic resonance imaging of the head, and polymerase chain reaction (PCR) analysis of cerebrospinal fluid for herpes simplex type 1 DNA is a sensitive and specific way of diagnosing HSE for proper treatment. • Early treatment is essential. HSE is treated with acyclovir 10 mg/kg every 8 hours intravenously for 21 days, unless the illness is mild, or if nephrotoxicity occurs. • Whether prolonged therapy with oral antiviral treatment after standard intravenous acyclovir offers any advantage from the standpoint of neurologic morbidity or mortality is unproven. • PCR-negative typical cases and PCR-positive atypical cases of HSE can occur and require treatment with acyclovir.

Original languageEnglish (US)
Pages (from-to)145-150
Number of pages6
JournalCurrent Treatment Options in Neurology
Volume7
Issue number2
DOIs
StatePublished - Mar 2005

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Herpes simplex encephalitis in adults and older children'. Together they form a unique fingerprint.

  • Cite this